Recombinant Rituximab antibody
Quick Overview for Recombinant Rituximab antibody (ABIN7482277)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Purpose
- Anti-Rituximab Antibody (MALS verified)
-
Characteristics
- Anti-idiotypic Antibodies
-
Immunogen
- Anti-Rituximab Antibody (ABIN7482277) are expressed from human 293 cells (HEK293).
-
-
-
-
Application Notes
- This antibody can be paired with other CD20 antibodies to detect CD20 in sandwich ELISA or LFA assay.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Storage
- -20 °C
-
-
- Rituximab
-
Target Type
- Antibody
-
Background
- Rituxan is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light- and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids, Anti-Rituximab Antibodies (RIB-Y35c) is the monoclonal antibody of Rituximab expressed with human HEK293 cells.
Target
-